NEWS & VIEWS
Unified News, Views, & Blogs
On July 28, 2026, Unified filed an ex parte reexamination proceeding against U.S. Patent 10,298,644, owned and asserted by InstaCom LLC, an NPE and entity of Elon Life LLC. The '644 patent relates to an instant communications system having established communication channels between communication devices. It was previously asserted against Samsung.
View district court litigations by InstaCom. Unified is represented by in-house by Kyla Butler and Jordan Rossen in this proceeding.
Unified Patents is pleased to announce the launch of its new MedTech Zone, expanding its proven deterrence model into the rapidly growing medical technology sector. The MedTech Zone was established with the support of leading industry participants and reflects the increasing need for a coordinated defense against non-practicing entities (NPEs), commonly known as patent trolls, targeting medical technology innovators.
The MedTech Zone expands Unified's proven deterrence model into the rapidly growing medical technology sector, where NPEs increasingly target manufacturers, healthcare providers, software developers, and suppliers with low-quality patents and costly litigation demands. As medical devices become more connected, software-driven, and data-intensive, the industry faces heightened exposure to NPE activity that can divert resources away from research, development, and patient care.
With the support of industry leading medical technology Unified members, Unified will proactively deter invalid patent assertions through its comprehensive enforcement and intelligence platform. These efforts include filing ex parte reexaminations, crowdsourcing prior art through PATROLL, publishing defensive prior art, monitoring NPE activity, and pursuing resolutions that eliminate litigation threats without paying patent trolls. Unified's unique model aligns industry participants around a common goal: reducing the incentives for NPEs to target productive companies and healthcare innovators.
The MedTech Zone joins Unified's growing portfolio of technology-focused deterrence zones that collectively protect thousands of companies from abusive patent assertions. By bringing together stakeholders across the medical technology ecosystem, Unified seeks to improve patent quality, reduce unnecessary litigation costs, and help ensure that investment remains focused on advancing life-saving technologies and improving patient outcomes rather than defending against meritless patent claims.
To learn more about MedTech Zone membership or Unified's other services, contact sasha@unifiedpatents.com.
On July 24, 2026, Unified filed an ex parte reexamination proceeding against U.S. Patent 10,651,992, owned by Wilus Institute of Standards & Technology, Inc., an entity of Good Day to Invent, Inc. The '992 patent relates to a wireless communication method for coexistence between a legacy wireless communication terminal and a non-legacy wireless communication terminal in a wireless communication environment. It has been asserted against Wi-Fi 6 (802.11ax) enabled network devices made by TP-Link and Askey Computer.
View district court litigations by Wilus. Unified is represented by in-house counsel, Vinu Raj and TJ Murphy, in this proceeding.
Unified Patents added a new PATROLL contest, with a $2,000 cash prize, seeking prior art on at least claim 1 of U.S. Patent 9,448,603, owned and asserted by Electronic Edison Transmission Technologies LLC, an NPE and entity of Leigh M. Rothschild. The '603 patent relates to transferring power from one portable/mobile device to another, especially when no outlet or charger is available. A “donor” device with remaining battery power charges a “receptor” device, such as a laptop charging a phone. It is currently asserted against Hyundai but has been asserted against Samsung, Google, Motorola Solutions, Belkin, and Nothing Technology in the past.
The contest will expire on August 31, 2026. Please visit PATROLL for more information and to submit an entry for the contest. PATROLL researchers are required to use Pearl to generate claim charts. Submitted invalidity charts must address every limitation of the challenged claim. This may require using more than one prior art reference. Each PATROLL researcher can generate up to 30 invalidity claim charts per month using Pearl. These charts can be downloaded then submitted to PATROLL.
On July 17, 2026, Unified filed an ex parte reexamination proceeding against U.S. Patent 12,395,899, another patent owned by Malikie Innovations Limited, an NPE and entity of Key Patent Innovations Limited. The ‘899 patent relates to the negotiation of the prioritization of network management traffic by Wi-Fi stations and access points. This negotiation involves transmitting management frame quality of service (MFQ) policies and requests for changes to MFQ policies between stations and access points. Malikie Innovations has filed several other litigations funded by Key Patent Innovations Limited against networking communications, apps, and Wi-Fi devices.
View district court litigations by Malikie. Unified is represented by Stephen Cortiaus and Payam Rashidi of Slater Matsil, and in-house by Jessica L.A. Marks and T.J. Murphy in this proceeding.
